Premium
Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes
Author(s) -
Plener Paul L,
Molz Esther,
Berger Gabriele,
Schober Edith,
Mönkemöller Kirsten,
Denzer Christian,
Goldbeck Lutz,
Holl Reinhard W
Publication year - 2015
Publication title -
pediatric diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 75
eISSN - 1399-5448
pISSN - 1399-543X
DOI - 10.1111/pedi.12130
Subject(s) - medicine , depression (economics) , antidepressant , diabetes mellitus , diabetic ketoacidosis , hypoglycemia , ketoacidosis , type 1 diabetes , type 2 diabetes , observational study , pediatrics , psychiatry , endocrinology , hippocampus , economics , macroeconomics
Objective Recent literature suggests an association between type 1 diabetes ( T1D ) and depression. So far, most studies explored this link in adult populations, with few data being available on diabetes and depression from minors and young adults. This study aimed to look for associations between symptoms of depression/antidepressant treatment and metabolic outcomes of T1D . Methods We conducted an observational study using the German diabetes database (Diabetes‐Patienten‐Verlaufsdokumentation – DPV ) and searched for patients up to the age of 25 yr, with depressive symptoms and/or receiving antidepressant medication. Results Of 53 986 T1D patients below the age of 25 yr, antidepressant medication and/or depressive symptoms were reported in 419 (0.78%). After adjustment for age, gender, diabetes duration and center heterogeneity, minors and young adults with depressive symptoms showed worse outcome parameters such as a higher rate of severe hypoglycemia (0.56 vs. 0.20/patient year, p = 0.005) and more episodes of diabetic ketoacidosis (0.20 vs. 0.07/patient year, p < 0.001). Hemoglobin A1c ( HbA1c ) was higher in the depression group (74.50 vs. 67.58 mmol/mol, p < 0.001) and young patients with T1D and depression showed longer duration of inpatient treatment (7.04 vs. 3.10 hospital days/patient year, p < 0.001) and more frequent admissions to hospital care (0.63 vs. 0.32/patient year, p < 0.001). Antidepressant medication was recorded in 52.3% of the depressed patients, with selective serotonin reuptake inhibitors ( SSRIs ) being the most widely described class of antidepressants (29.1%). Conclusions Our findings demonstrate an adverse treatment outcome for young patients with T1D and comorbid depressive symptoms underlining an urgent need for collaborative mental and somatic health care for patients with T1D and depression.